Beta Bionics hit net sales of $44.7m in the first nine months of 2024, marking an increase from $3.6m in 2023. Beta Bionics’ ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

BECKLEY, W.Va. — Jury deliberations begin Wednesday morning in the murder trial of former Raleigh County pharmacist Natalie ...

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient“whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets or ...